Introduction
Modern radiotherapy relies on advanced techniques (beam modulation, arc delivery, etc.) to deliver high radiation doses to irregularly shaped, small volume targets [1] . At present, commissioning of equipment and quality assurance of treatments are most often performed by a combination of one-or twodimensional detectors, e.g. ion chambers, diode arrays and films [2] . However, these methods can provide only sparse three-dimensional (3D) data, which complicates the quality assurance process and adds uncertainty to its results [3] . To overcome this issue, the use of "true 3D" dosimetry has been proposed and multiple 3D dosimeters have been developed. These include gel, plastic and elastic (e.g. silicone-based) dosimeters with signal detection via magnetic resonance imaging or optical computed tomography [4] . Notwithstanding the wide variety of materials, true 3D dosimetry still has a limited clinical application, because of multiple drawbacks: poor chemical and/or image stability due to spontaneous colour change and/or signal diffusion within the dosimeter, complex and complicated preparation and use, imaging and data analysis.
The radiochromic gel discussed here was designed to provide chemically stable 3D dosimetry with no apparent signal diffusion. This allows dosimeter manufacturing, pre-irradiation and postirradiation imaging to be handled at an off-site facility, as a commercial product. The dosimeter is based on the radiochromic reduction of a colourless, water-soluble tetrazolium salt into an insoluble formazan dye suspended in gellan gum gel, as discussed in part I of this paper. The composition has been licensed to Modus QA (Modus Medical Devices Inc.) and developed as a product under the name ClearView. Here, the dosimetric characterization of ClearView gel in small (4mL) and large (1 L) volumes is presented.
Materials and Methods

Gel manufacturing
A 20-litre jacketed process reactor, described previously [5] , was used for the manufacturing of 12 to 18-litre batches of ClearView with the following composition per litre: 12.50 g gellan gum (Alfa Aesar, USA, cat. no.: J63423), 103.60 g propylene glycol (AMRESCO, USA, cat. no.: 0575), 42.5 mg (0.10 mmol) 2,3-bis(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (BNC) (Expert Synthesis Solutions, London, Canada) and deionized water. The gellan gum was dissolved at temperatures over 85 °C but the active ingredients were added at 70 °C. The hot solution was filtered through a 1.0 or 0.5 µm filter and poured into one-litre clear polyethylene terephthalate jars. Controlled cooling allowed gel formation before storage at 4-6 °C. Simultaneously, poly(methyl methacrylate) (PMMA) cuvettes (1.0 cm square cross-section, 4 mL volume) were filled. The density of the gels at room temperature was determined with a 250-mL volumetric flask using three samples from two batches.
General set-up and irradiations
Optical measurements for the cuvettes were performed on a GENESYS 10S spectrophotometer (Thermo Fisher Scientific, Canada) at 535 nm, while the jars were imaged on a Vista 15 optical cone beam CT scanner with a green LED source (520-535 nm) (Modus QA, London, Canada). Irradiations took place within 2 to 5 days of preparation of the gels, which were pre-scanned on the day of irradiation, and postscanned the following day with follow-up of up to 58 days. Irradiations were performed on either of two linear accelerators from Varian Medical Systems (USA): Clinac 21iX and TrueBeam at the London Regional Cancer Program (London, Canada). Cuvettes were placed three to six at a time on a PMMA block and submerged into water to a depth of 5 cm to the centre of the cuvette (for photons) or d max (for electrons) and irradiated using 10x10 cm square beams. The 1-litre jars were irradiated using 6x6 cm square beams of photons or electrons, unless otherwise noted. The water surface over the cuvettes and the top surface of the gels were positioned at 100 cm source to surface distance. Percentage depth dose curves (PDD) were obtained as described elsewhere [6] , and referenced to CC13 (IBA Dosimetry America, USA) ion chamber measurements. To determine the linearity and stability of the dose response, cuvettes were irradiated up to 80 Gy at 600 cGy/min using 6 MV photons and 12 MeV electron beams. For the sensitivity in large samples, jars from three different batches were irradiated with 12MeV electrons to 40 Gy (at dmax) at 600 cGy/min [7] . The energy sensitivity to dose response was tested at 20 Gy, using 6 to 18 MV photons and 6 to 20 MeV electrons at 600 cGy/min in cuvettes from two different batches of gel. To test the sensitivity of the dose response to a wider range of energies and dose rates, cuvettes and jars of different batches were irradiated to 20 Gy at a range of electron and photon energies and dose rates, including flattening filter free (FFF) deliveries. Finally, a dose fractionation experiment was performed using arc treatments to 40 Gy at the isocenter using 6 MV photons at 600 cGy/min in two different settings: (i) in a single fraction, (ii) in five fractions of 8 Gy delivered sequentially.
Results and discussion
Physical characteristics
ClearView appears colourless or pink-tinted before irradiation and becomes purple upon irradiation. The gel is strong and inelastic at room temperature with a volumetric mass density of 1009±1 g/L at 20 °C. The atomic composition (in mole percent) is 65.94% H, 31.35% O and 2.71% C. According to Figure 1A both photon and electron beams gave identical response in the cuvettes, while dose calibration in a jar showed lower but linear sensitivity. The decreased sensitivity in jars is likely due to the wider bandwidth of the LED source relative to the spectrophotometer used for the cuvette samples. The attenuation profile within the jar remained constant for at least 58 days, showing neither diffusion nor changing magnitude ( Figure 1B) , while both non-irradiated and irradiated cuvette samples remained stable for at least 21 days with noticeable drying of the gel thereafter ( Figure 1C ). . The sensitivity variability can be attributed to two main factors: differences in the properties of the raw materials and changing process conditions. Here, the gellan gum used in the fabrication of the first batch (lot no. R13B050) had a different gel strength than the gellan gum used in batches 2 and 3 (lot no. Z22B034): 497 g/cm 2 and 606 g/cm 2 , respectively, even though the supplier and catalog numbers were identical (Alfa Aesar, J63423). Further, the filtration process was updated between batches 2 and 3: from 1.0 to 0.5 µm filtration. Regardless of the different sensitivities, all tested batches showed consistent PDD curves, in agreement with the ion chamber measurements (Fig. 2B) . on the jar data, which is less noisy and more clinically relevant than the cuvette data, the sensitivity is constant within samples of the same batch at dose rate above 400 cGy/min. Additionally, the fractionation experiment showed identical responses in jars irradiated in a single fraction of 40 Gy (6 MV photons, 600 cGy/min) and in five consecutive fractions of 8 Gy (data not shown). However, at dose rates below 400 cGy/min the sensitivity dropped ( Figure 3B ). We hypothesise that the decreased sensitivity below 400 cGy/min is associated with the low concentration of the active compound (BNC) in ClearView. Future research will focus on finding the mechanism of the dose rate effect with the goal of minimizing or eliminating it.
Dosimetric characteristics
Conclusions
The ClearView radiochromic gel showed excellent stability for both irradiated and non-irradiated samples, without apparent optical changes or diffusion within a period of at least two months from manufacturing in large-volume samples. Batch-to-batch variability was observed in regards to the sensitivity to the delivered dose ); however, the dose response was linear in all tested batches, identical for photons and electrons and unaffected by the energy in the range of 6 to 18 MV, and 6 to 20 MeV, respectively. However, there was a noticeable drop of the sensitivity at dose rates below 400 cGy/min. Thus, ClearView is best suited for relative dosimetry up to 80 Gy at high dose rates. Future research and product development will focus on minimizing the dose-rate effect and increasing the sensitivity of the ClearView gel.
